No association between ACE olymorphism and risk of nasopharyngeal carcinoma

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 13, Issue 1, 2012, Pages 210-215

  Li, Zhao Hui ^a   Pan, Xin Min ^b   Han, Bao Wei ^a   Han, Hong Bin ^a   Zhang, Zhen ^b   Gao, Lin Bo ^c  

^a Luoyang Central Hospital   (China)

^b HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

ACE; nasopharyngeal carcinoma; polymorphism

Indexed keywords

ASPARTIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE; ISOLEUCINE; ACE PROTEIN, HUMAN;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENE IDENTIFICATION; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; CASE CONTROL STUDY; ENZYMOLOGY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; INDEL MUTATION; MIDDLE AGED; NASOPHARYNX TUMOR; RISK FACTOR;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDEL MUTATION; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 84859947461     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320311426168     Document Type: Article

References (50)

1. McDermott AL, Dutt SN and Watkinson JC. The aetiology of nasopharyngeal carcinoma. Clin Otolaryngol Allied Sci 2001; 26: 82-92. (Pubitemid 32368223)
2. Chang ET and Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 2006; 15: 1765-1777. (Pubitemid 44664247)
3. Chen DL and Huang TB. A case-control study of risk factors of nasopharyngeal carcinoma. Cancer Lett 1997; 117: 17-22.
4. Yu MC and Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 2002; 12: 421-429. (Pubitemid 35370755)
5. Zheng X, Yan L, Nilsson B, Eklund G and Drettner B. Epstein-Barr virus infection, salted fish and nasopharyngeal carcinoma. A case-control study in southern China. Acta Oncol 1994; 33: 867-872.
6. Gao LB, Liang WB, Xue H, et al. Genetic polymorphism of interleukin-16 and risk of nasopharyngeal carcinoma. Clin Chim Acta 2009; 409: 132-135.
7. Zhou B, Rao L, Li Y, et al. A functional insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for nasopharyngeal carcinoma. Cancer Lett 2009; 275: 72-76.
8. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V and Egido J. Inflammation and angiotensin II. Int J Biochem Cell Biol 2003; 35: 881-900. (Pubitemid 36379329)
9. Volpert OV, Ward WF, Lingen MW, et al. Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. J Clin Invest 1996; 98: 671-679. (Pubitemid 26349171)
10. Yoshiji H, Kuriyama S, Kawata M, et al. The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor. Clin Cancer Res 2001; 7: 1073-1078. (Pubitemid 32708747)
11. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P and Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346. (Pubitemid 20370444)
12. Nakai K, Itoh C, Miura Y, et al. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 1994; 90: 2199-2202. (Pubitemid 24354301)
13. Winkelmann BR, Nauck M, Klein B, et al. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease. Ann Intern Med 1996; 125: 19-25.
14. Yaren A, Turgut S, Kursunluoglu R, et al. Association between the polymorphism of the angiotensin-converting enzyme gene and tumor size of breast cancer in premenopausal patients. Tohoku J Exp Med 2006; 210: 109-116. (Pubitemid 44575585)
15. Yaren A, Turgut S, Kursunluoglu R, et al. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients with breast cancer and effects on prognostic factors. J Investig Med 2007; 55: 255-261. (Pubitemid 47555944)
16. Yuan JM, Koh WP, Sun CL, Lee HP and Yu MC. Green tea intake, ACE gene polymorphism and breast cancer risk among Chinese women in Singapore. Carcinogenesis 2005; 26: 1389-1394. (Pubitemid 41430093)
17. Koh WP, Yuan JM, Sun CL, et al. Angiotensin I-converting enzyme (ACE) gene polymorphism and breast cancer risk among Chinese women in Singapore. Cancer Res 2003; 63: 573-578.
18. Haiman CA, Henderson SO, Bretsky P, Kolonel LN and Henderson BE. Genetic variation in angiotensin I-converting enzyme (ACE) and breast cancer risk: the multiethnic cohort. Cancer Res 2003; 63: 6984-6987. (Pubitemid 37322985)
19. Alves Correa SA, Ribeiro de Noronha SM, Nogueira-de-Souza NC, et al. Association between the angiotensin-converting enzyme (insertion/deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms and breast cancer among Brazilian women. J Renin Angiotensin Aldosterone Syst 2009; 10: 51-58.
20. Koh WP, Yuan JM, Van Den Berg D, Lee HP and Yu MC. Polymorphisms in angiotensin II type 1 receptor and angiotensin I-converting enzyme genes and breast cancer risk among Chinese women in Singapore. Carcinogenesis 2005; 26: 459-464. (Pubitemid 40246568)
21. Gonzalez-Zuloeta Ladd AM, Arias Vasquez A, Sayed-Tabatabaei FA, et al. Angiotensin-converting enzyme gene insertion/deletion polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005; 14: 2143-2146. (Pubitemid 41603259)
22. Sugimoto M, Furuta T, Shirai N, Ikuma M, Sugimura H and Hishida A. Influences of chymase and angiotensin I-converting enzyme gene polymorphisms on gastric cancer risks in Japan. Cancer Epidemiol Biomarkers Prev 2006; 15: 1929-1934. (Pubitemid 44664270)
23. Röcken C, Rohl FW, Diebler E, et al. The angiotensin II/angiotensin II receptor system correlates with nodal spread in intestinal type gastric cancer. Cancer Epidemiol Biomarkers Prev 2007; 16: 1206-1212. (Pubitemid 46984960)
24. Röcken C, Lendeckel U, Dierkes J, et al. The number of lymph node metastases in gastric cancer correlates with the angiotensin I-converting enzyme gene insertion/deletion polymorphism. Clin Cancer Res 2005; 11: 2526-2530. (Pubitemid 40569449)
25. Ebert MP, Lendeckel U, Westphal S, et al. The angiotensin I-converting enzyme gene insertion/deletion polymorphism is linked to early gastric cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 2987-2989. (Pubitemid 43068835)
26. Goto Y, Ando T, Nishio K, et al. The ACE gene polymorphism is associated with the incidence of gastric cancer among H. pylori seropositive subjects with atrophic gastritis. Asian Pac J Cancer Prev 2005; 6: 464-467.
27. Toma M, Cimponeriu D, Apostol P, et al. Lack of association between ACE ID polymorphism and colorectal cancer in Romanian patients. Chirurgia (Bucur) 2009; 104: 553-556.
28. van der Knaap R, Siemes C, Coebergh JW, van Duijn CM, Hofman A and Stricker BH. Renin-angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer: the Rotterdam Study. Cancer 2008; 112: 748-757. (Pubitemid 351240568)
29. Röcken C, Neumann K, Carl-McGrath S, et al. The gene polymorphism of the angiotensin I-converting enzyme correlates with tumor size and patient survival in colorectal cancer patients. Neoplasia 2007; 9: 716-722. (Pubitemid 47523233)
30. Nikiteas N, Tsigris C, Chatzitheofylaktou A and Yannopoulos A. No association with risk for colorectal cancer of the insertion/deletion polymorphism which affects levels of angiotensin-converting enzyme. In Vivo 2007; 21: 1065-1068. (Pubitemid 350286337)
31. Sameer A, Nissar S, Bashir S, Bashir A and Siddiqi M. ACE Polymorphism in Colorectal Cancer Patients of Kashmiri Population - A Short Report. The Open Colorectal Cancer Journal 2011; 4: 1-5.
32. Sierra Diaz E, Sanchez Corona J, Rosales Gomez RC, et al. Angiotensin-converting enzyme insertion/deletion and angiotensin type 1 receptor A1166C polymorphisms as genetic risk factors in benign prostatic hyperplasia and prostate cancer. J Renin Angiotensin Aldosterone Syst 2009; 10: 241-246.
33. Yigit B, Bozkurt N, Narter F, Yilmaz H, Yucebas E and Isbir T. Effects of ACE I/D polymorphism on prostate cancer risk, tumor grade and metastatis. Anticancer Res 2007; 27: 933-936. (Pubitemid 46587002)
34. Medeiros R, Vasconcelos A, Costa S, et al. Linkage of angiotensin I-converting enzyme gene insertion/deletion polymorphism to the progression of human prostate cancer. J Pathol 2004; 202: 330-335. (Pubitemid 38325242)
35. Cheon KT, Choi KH, Lee HB, Park SK, Rhee YK and Lee YC. Gene polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in patients with lung cancer. Lung 2000; 178: 351-360. (Pubitemid 32368237)
36. Yaren A, Oztop I, Turgut S, Turgut G, Degirmencioglu S and Demirpence M. Angiotensin-converting enzyme gene polymorphism is associated with anemia in non small-cell lung cancer. Exp Biol Med (Maywood) 2008; 233: 32-37.
37. Vairaktaris E, Yapijakis C, Tsigris C, et al. Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancer. Acta Oncol 2007; 46: 1097-1102. (Pubitemid 350058878)
38. Vairaktaris E, Serefoglou Z, Avgoustidis D, et al. Gene polymorphisms related to angiogenesis, inflammation and thrombosis that influence risk for oral cancer. Oral Oncol 2009; 45: 247-253.
39. Usmani BA, Janeczko M, Shen R, Mazumdar M, Papandreou CN and Nanus DM. Analysis of the insertion/deletion polymorphism of the human angiotensin converting enzyme (ACE) gene in patients with renal cancer. Br J Cancer 2000; 82: 550-552. (Pubitemid 30085189)
40. Ruggenenti P, Perna A, Zoccali C, et al. Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: differences between women and men in relation to the ACE gene polymorphism. Gruppo Italiano di Studi Epidemologici in Nefrologia (Gisen). J Am Soc Nephrol 2000; 11: 88-96. (Pubitemid 30020430)
41. Chung FM, Yang YH, Chen CH, Lin CC and Shieh TY. Angiotensin-converting enzyme gene insertion/deletion polymorphism is associated with risk of oral precancerous lesion in betel quid chewers. Br J Cancer 2005; 93: 602-606. (Pubitemid 43080006)
42. Bauvois B. Transmembrane proteases in cell growth and invasion: new contributors to angiogenesis? Oncogene 2004; 23: 317-329. (Pubitemid 38174985)
43. Ruiter R, Visser LE, Van Duijn CM and Ch Stricker BH. The ACE insertion/deletion polymorphism and risk of cancer, a review and meta-analysis of the literature. Curr Cancer Drug Targets 2011; 11: 421-430.
44. Yang JK, Gong YY, Xie L, et al. Lack of genetic association between the angiotensin-converting enzyme gene insertion/deletion polymorphism and longevity in a Han Chinese population. J Renin Angiotensin Aldosterone Syst 2009; 10: 115-118.
45. Yan C, Zhan J and Feng W. Gene polymorphisms of angiotensin II type 1 receptor and angiotensin-converting enzyme in two ethnic groups living in Zhejiang Province, China. J Renin Angiotensin Aldosterone Syst 2005; 6: 132-137. (Pubitemid 43263351)
46. Sun J, Fan H, Che Y, et al. Association between ACE gene I/D polymorphisms and hyperandrogenism in women with polycystic ovary syndrome (PCOS) and controls. BMC Med Genet 2009; 10: 64.
47. Daimon M, Oizumi T, Saitoh T, et al. The D allele of the angiotensin-converting enzyme insertion/ deletion (I/D) polymorphism is a risk factor for type 2 diabetes in a population-based Japanese sample. Endocr J 2003; 50: 393-398. (Pubitemid 37129031)
48. Choi YH, Kim JH, Kim DK, et al. Distributions of ACE and APOE polymorphisms and their relations with dementia status in Korean centenarians. J Gerontol A Biol Sci Med Sci 2003; 58: 227-231. (Pubitemid 36307593)
49. Panza F, Solfrizzi V, D'Introno A, et al. Angiotensin I converting enzyme (ACE) gene polymorphism in centenarians: different allele frequencies between the North and South of Europe. Exp Gerontol 2003; 38: 1015-1020. (Pubitemid 37040803)
50. Blanche H, Cabanne L, Sahbatou M and Thomas G. A study of French centenarians: are ACE and APOE associated with longevity? C R Acad Sci III 2001; 324: 129-135. (Pubitemid 33130183)